Livzon Pharma discloses share repurchase activities

Livzon Pharmaceutical Group Co., Ltd. (SZSE:000513) has released a next-day disclosure report detailing its share repurchase activities. On April 11, 2025, the company repurchased 291,400 A-shares on the Shenzhen Stock Exchange for a total consideration of RMB9,998,429. The highest repurchase price per share was RMB34.45, and the lowest was RMB34.17. The company also repurchased 0 H-shares on the Hong Kong exchange. As of April 11, 2025, Livzon's total issued share count stands at 604,293,313 A-shares and 307,052,417 H-shares. The company affirmed that the repurchases complied with relevant regulations.